Global Injectable Drug Delivery Devices Market Research Report 2021

1 Injectable Drug Delivery Devices Market Overview

• 1.1 Product Overview and Scope of Injectable Drug Delivery Devices
• 1.2 Injectable Drug Delivery Devices Segment by Type
  • 1.2.1 Global Injectable Drug Delivery Devices Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Devices
  • 1.2.3 Formulation
• 1.3 Injectable Drug Delivery Devices Segment by Application
  • 1.3.1 Injectable Drug Delivery Devices Sales Comparison by Application: (2021-2027)
  • 1.3.2 Immune Disorder
  • 1.3.3 Cancer
  • 1.3.4 Diabetes
  • 1.3.5 Other
• 1.4 Global Injectable Drug Delivery Devices Market Size Estimates and Forecasts
  • 1.4.1 Global Injectable Drug Delivery Devices Revenue 2016-2027
  • 1.4.2 Global Injectable Drug Delivery Devices Sales 2016-2027
  • 1.4.3 Injectable Drug Delivery Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Injectable Drug Delivery Devices Market Competition by Manufacturers

• 2.1 Global Injectable Drug Delivery Devices Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Injectable Drug Delivery Devices Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Injectable Drug Delivery Devices Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Injectable Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
• 2.5 Injectable Drug Delivery Devices Market Competitive Situation and Trends
  • 2.5.1 Injectable Drug Delivery Devices Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Injectable Drug Delivery Devices Players Market Share by Revenue
  • 2.5.3 Global Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Injectable Drug Delivery Devices Retrospective Market Scenario by Region

• 3.1 Global Injectable Drug Delivery Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Injectable Drug Delivery Devices Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Injectable Drug Delivery Devices Market Facts & Figures by Country
  • 3.3.1 North America Injectable Drug Delivery Devices Sales by Country
  • 3.3.2 North America Injectable Drug Delivery Devices Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Injectable Drug Delivery Devices Market Facts & Figures by Country
  • 3.4.1 Europe Injectable Drug Delivery Devices Sales by Country
  • 3.4.2 Europe Injectable Drug Delivery Devices Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Injectable Drug Delivery Devices Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Injectable Drug Delivery Devices Sales by Region
  • 3.5.2 Asia Pacific Injectable Drug Delivery Devices Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Injectable Drug Delivery Devices Market Facts & Figures by Country
  • 3.6.1 Latin America Injectable Drug Delivery Devices Sales by Country
  • 3.6.2 Latin America Injectable Drug Delivery Devices Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Injectable Drug Delivery Devices Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Injectable Drug Delivery Devices Sales by Country
  • 3.7.2 Middle East and Africa Injectable Drug Delivery Devices Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Injectable Drug Delivery Devices Historic Market Analysis by Type

• 4.1 Global Injectable Drug Delivery Devices Sales Market Share by Type (2016-2021)
• 4.2 Global Injectable Drug Delivery Devices Revenue Market Share by Type (2016-2021)
• 4.3 Global Injectable Drug Delivery Devices Price by Type (2016-2021)

5 Global Injectable Drug Delivery Devices Historic Market Analysis by Application

• 5.1 Global Injectable Drug Delivery Devices Sales Market Share by Application (2016-2021)
• 5.2 Global Injectable Drug Delivery Devices Revenue Market Share by Application (2016-2021)
• 5.3 Global Injectable Drug Delivery Devices Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Dickinson and Company
  • 6.1.1 Dickinson and Company Corporation Information
  • 6.1.2 Dickinson and Company Description and Business Overview
  • 6.1.3 Dickinson and Company Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Dickinson and Company Product Portfolio
  • 6.1.5 Dickinson and Company Recent Developments/Updates
• 6.2 Baxter International
  • 6.2.1 Baxter International Corporation Information
  • 6.2.2 Baxter International Description and Business Overview
  • 6.2.3 Baxter International Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Baxter International Product Portfolio
  • 6.2.5 Baxter International Recent Developments/Updates
• 6.3 Schott
  • 6.3.1 Schott Corporation Information
  • 6.3.2 Schott Description and Business Overview
  • 6.3.3 Schott Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Schott Product Portfolio
  • 6.3.5 Schott Recent Developments/Updates
• 6.4 Eli Lilly
  • 6.4.1 Eli Lilly Corporation Information
  • 6.4.2 Eli Lilly Description and Business Overview
  • 6.4.3 Eli Lilly Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Eli Lilly Product Portfolio
  • 6.4.5 Eli Lilly Recent Developments/Updates
• 6.5 Pfizer
  • 6.5.1 Pfizer Corporation Information
  • 6.5.2 Pfizer Description and Business Overview
  • 6.5.3 Pfizer Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Pfizer Product Portfolio
  • 6.5.5 Pfizer Recent Developments/Updates
• 6.6 Gerresheimer
  • 6.6.1 Gerresheimer Corporation Information
  • 6.6.2 Gerresheimer Description and Business Overview
  • 6.6.3 Gerresheimer Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Gerresheimer Product Portfolio
  • 6.6.5 Gerresheimer Recent Developments/Updates
• 6.7 Terumo Corporation
  • 6.6.1 Terumo Corporation Corporation Information
  • 6.6.2 Terumo Corporation Description and Business Overview
  • 6.6.3 Terumo Corporation Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Terumo Corporation Product Portfolio
  • 6.7.5 Terumo Corporation Recent Developments/Updates
• 6.8 Antares Pharma
  • 6.8.1 Antares Pharma Corporation Information
  • 6.8.2 Antares Pharma Description and Business Overview
  • 6.8.3 Antares Pharma Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Antares Pharma Product Portfolio
  • 6.8.5 Antares Pharma Recent Developments/Updates
• 6.9 Novo Nordik
  • 6.9.1 Novo Nordik Corporation Information
  • 6.9.2 Novo Nordik Description and Business Overview
  • 6.9.3 Novo Nordik Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Novo Nordik Product Portfolio
  • 6.9.5 Novo Nordik Recent Developments/Updates
• 6.10 Sanofi
  • 6.10.1 Sanofi Corporation Information
  • 6.10.2 Sanofi Description and Business Overview
  • 6.10.3 Sanofi Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Sanofi Product Portfolio
  • 6.10.5 Sanofi Recent Developments/Updates
• 6.11 Unilife Corporation
  • 6.11.1 Unilife Corporation Corporation Information
  • 6.11.2 Unilife Corporation Injectable Drug Delivery Devices Description and Business Overview
  • 6.11.3 Unilife Corporation Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Unilife Corporation Product Portfolio
  • 6.11.5 Unilife Corporation Recent Developments/Updates
• 6.12 Zogenix
  • 6.12.1 Zogenix Corporation Information
  • 6.12.2 Zogenix Injectable Drug Delivery Devices Description and Business Overview
  • 6.12.3 Zogenix Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Zogenix Product Portfolio
  • 6.12.5 Zogenix Recent Developments/Updates
• 6.13 Hospira
  • 6.13.1 Hospira Corporation Information
  • 6.13.2 Hospira Injectable Drug Delivery Devices Description and Business Overview
  • 6.13.3 Hospira Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Hospira Product Portfolio
  • 6.13.5 Hospira Recent Developments/Updates
• 6.14 Presage Bioscience
  • 6.14.1 Presage Bioscience Corporation Information
  • 6.14.2 Presage Bioscience Injectable Drug Delivery Devices Description and Business Overview
  • 6.14.3 Presage Bioscience Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Presage Bioscience Product Portfolio
  • 6.14.5 Presage Bioscience Recent Developments/Updates
• 6.15 MicroCHIPS
  • 6.15.1 MicroCHIPS Corporation Information
  • 6.15.2 MicroCHIPS Injectable Drug Delivery Devices Description and Business Overview
  • 6.15.3 MicroCHIPS Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 MicroCHIPS Product Portfolio
  • 6.15.5 MicroCHIPS Recent Developments/Updates
• 6.16 Pearl Therapeutics
  • 6.16.1 Pearl Therapeutics Corporation Information
  • 6.16.2 Pearl Therapeutics Injectable Drug Delivery Devices Description and Business Overview
  • 6.16.3 Pearl Therapeutics Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Pearl Therapeutics Product Portfolio
  • 6.16.5 Pearl Therapeutics Recent Developments/Updates
• 6.17 Genentech
  • 6.17.1 Genentech Corporation Information
  • 6.17.2 Genentech Injectable Drug Delivery Devices Description and Business Overview
  • 6.17.3 Genentech Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Genentech Product Portfolio
  • 6.17.5 Genentech Recent Developments/Updates
• 6.18 Bend Research
  • 6.18.1 Bend Research Corporation Information
  • 6.18.2 Bend Research Injectable Drug Delivery Devices Description and Business Overview
  • 6.18.3 Bend Research Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Bend Research Product Portfolio
  • 6.18.5 Bend Research Recent Developments/Updates

7 Injectable Drug Delivery Devices Manufacturing Cost Analysis

• 7.1 Injectable Drug Delivery Devices Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Injectable Drug Delivery Devices
• 7.4 Injectable Drug Delivery Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Injectable Drug Delivery Devices Distributors List
• 8.3 Injectable Drug Delivery Devices Customers

9 Injectable Drug Delivery Devices Market Dynamics

• 9.1 Injectable Drug Delivery Devices Industry Trends
• 9.2 Injectable Drug Delivery Devices Growth Drivers
• 9.3 Injectable Drug Delivery Devices Market Challenges
• 9.4 Injectable Drug Delivery Devices Market Restraints

10 Global Market Forecast

• 10.1 Injectable Drug Delivery Devices Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Injectable Drug Delivery Devices by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Injectable Drug Delivery Devices by Type (2022-2027)
• 10.2 Injectable Drug Delivery Devices Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Injectable Drug Delivery Devices by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Injectable Drug Delivery Devices by Application (2022-2027)
• 10.3 Injectable Drug Delivery Devices Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Injectable Drug Delivery Devices by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Injectable Drug Delivery Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List